Inhibitors of the chemokine receptor CxCR3
Disclosed is a 3-(amido or sulfamido)-4-(4-substituted-azinyl)benzamide or benzsulfonamide compound of formula (I) where Q and Y are CO or SO2, X is halo, m is 1-3, R5 is a monovalent group as described or is a spiro ring as described, and wherein the other substituents are as described in the speci...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | THORPE, DAVID S |
description | Disclosed is a 3-(amido or sulfamido)-4-(4-substituted-azinyl)benzamide or benzsulfonamide compound of formula (I) where Q and Y are CO or SO2, X is halo, m is 1-3, R5 is a monovalent group as described or is a spiro ring as described, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound to treat CxCR3 chemokine receptor mediated diseases or conditions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ587380A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ587380A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ587380A3</originalsourceid><addsrcrecordid>eNrjZNDyzMvITMosyS8qVshPUyjJSFVIzkjNzc_OzEtVKEpNTi0ASik4VzgHGfMwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUkni_KFMLc2MLA0djggoAHbkngg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of the chemokine receptor CxCR3</title><source>esp@cenet</source><creator>THORPE, DAVID S</creator><creatorcontrib>THORPE, DAVID S</creatorcontrib><description>Disclosed is a 3-(amido or sulfamido)-4-(4-substituted-azinyl)benzamide or benzsulfonamide compound of formula (I) where Q and Y are CO or SO2, X is halo, m is 1-3, R5 is a monovalent group as described or is a spiro ring as described, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound to treat CxCR3 chemokine receptor mediated diseases or conditions.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110930&DB=EPODOC&CC=NZ&NR=587380A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110930&DB=EPODOC&CC=NZ&NR=587380A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THORPE, DAVID S</creatorcontrib><title>Inhibitors of the chemokine receptor CxCR3</title><description>Disclosed is a 3-(amido or sulfamido)-4-(4-substituted-azinyl)benzamide or benzsulfonamide compound of formula (I) where Q and Y are CO or SO2, X is halo, m is 1-3, R5 is a monovalent group as described or is a spiro ring as described, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound to treat CxCR3 chemokine receptor mediated diseases or conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDyzMvITMosyS8qVshPUyjJSFVIzkjNzc_OzEtVKEpNTi0ASik4VzgHGfMwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUkni_KFMLc2MLA0djggoAHbkngg</recordid><startdate>20110930</startdate><enddate>20110930</enddate><creator>THORPE, DAVID S</creator><scope>EVB</scope></search><sort><creationdate>20110930</creationdate><title>Inhibitors of the chemokine receptor CxCR3</title><author>THORPE, DAVID S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ587380A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>THORPE, DAVID S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THORPE, DAVID S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of the chemokine receptor CxCR3</title><date>2011-09-30</date><risdate>2011</risdate><abstract>Disclosed is a 3-(amido or sulfamido)-4-(4-substituted-azinyl)benzamide or benzsulfonamide compound of formula (I) where Q and Y are CO or SO2, X is halo, m is 1-3, R5 is a monovalent group as described or is a spiro ring as described, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound to treat CxCR3 chemokine receptor mediated diseases or conditions.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ587380A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Inhibitors of the chemokine receptor CxCR3 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THORPE,%20DAVID%20S&rft.date=2011-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ587380A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |